A News

Agilent Refurbishment Centers Achieve Top-Level My Green Lab Certification

A

(NYSE:A) SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its Refurbishment Centers in Delaware, USA, and Singapore have achieved the highest level of My Green Lab Certification—Green level— an internationally recognized benchmark for laboratory sustainability. This milestone underscores Agilent’s commitment to environmental stewardship and innovation in sustainable lab operations. The certification process commenced in April 2024. Following a year of sustai

Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

A

(NYSE:A) SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced its participation as a premium sponsor at the upcoming European Congress of Pathology (ECP) 2025, taking place in Vienna, Austria, from September 6–10, 2025. Agilent will spotlight the European launch of its newly expanded Dako Omnis Family of instruments. The Dako Omnis family, including the Dako Omnis 110, 165, and 165 Duo models, is built to provide flexibility, consistency, and efficiency across labs o

Agilent’s MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer

A

(NYSE:A) SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer. MMR IHC Panel pharmDx (Dako Omnis) is indicated as an aid to identify mismatch repair (MMR) deficient CRC patients eligible for treatment with OPDIVO® (nivolumab) in combination with YERVOY® (ipilimumab). MMR IHC Panel

September 2, 2025Regulation
Read more →

Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results

A

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.74 billion for the third quarter ended July 31, 2025, exceeding revenue guidance and representing growth of 10.1% reported and up 6.1% core(1) compared with the third quarter of 2024. Third-quarter GAAP net income was $336 million, or $1.18 per share. This compares with $282 million, or $0.97 per share, in the third quarter of 2024. Non-GAAP(2) net income was $390 million, or $1.37 per share d

August 27, 2025Earnings
Read more →

Agilent to Participate in 2025 Wells Fargo Healthcare Conference

A

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that President and CEO Padraig McDonnell will participate in a fireside chat at this year’s Wells Fargo Healthcare Conference. The fireside chat will be at 11-11:35 a.m. Eastern on Wednesday, Sept. 3, in Everett, Massachusetts, outside of Boston. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website. About Agilent Technologies Agilent Technologies I

August 21, 2025Events
Read more →

Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval as a Companion Diagnostic Test for Colorectal Cancer

A

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for colorectal cancer. This test aids in identifying mismatch repair deficient (dMMR) colorectal cancer (CRC) patients who are eligible for treatment with Bristol Myers Squibb’s Opdivo® (nivolumab) alone or Opdivo (nivolumab) in combination with Yervoy® (ipilimumab). The MMR IHC Panel pharmDx (Dako Om

Shane Snyder to Lead New Agilent Center of Excellence at Georgia Tech Focused on Water and the Environment

A

SANTA CLARA, Calif. & ATLANTA--(BUSINESS WIRE)--Agilent Technologies Inc. and Georgia Tech today announced the establishment of an Agilent Center of Excellence (CoE) for Environmental Health and Engineering to advance research in environmental sustainability, water recycling, and biologics. Internationally recognized environmental scientist Professor Shane Snyder from the School of Civil and Environmental Engineering at Georgia Tech will lead the Agilent CoE. The CoE will foster collaboration a

Agilent to Showcase New Products and Innovations at HPLC 2025

A

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spectrometers at the upcoming HPLC 2025 conference in Bruges, Belgium. These new additions are designed to boost laboratory efficiency and deliver superior results. Exhibition attendees will be able to see how these products can streamline operations and enhance analytical outcomes. The Agilent Infinit

Agilent to Showcase New Products and Innovations at HPLC 2025

A

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spectrometers at the upcoming HPLC 2025 conference in Bruges, Belgium. These new additions are designed to boost laboratory efficiency and deliver superior results. Exhibition attendees will be able to see how these products can streamline operations and enhance analytical outcomes. The Agilent Infinit

UBS Maintains Neutral on Agilent Technologies, Lowers Price Target to $130

A

May 29, 2025
Read more →

Stocks Edge Higher After Court Stifles Trump Tariffs, Nvidia Rallies To 3-Month Highs, Bitcoin Dips Below $107K: What's Driving Markets Thursday?

A

Wall Street hovered slightly higher by midday Thursday, giving up a chunk of strong overnight gains in futures markets that were triggered by a federal court ruling suspending a large portion of President Donald Trump’s tari

May 29, 2025
Read more →

JP Morgan Maintains Overweight on Agilent Technologies, Lowers Price Target to $155

A

May 29, 2025
Read more →

Veeva Systems, e.l.f. Beauty, C3.ai, BRP And Other Big Stocks Moving Higher On Thursday

A

May 29, 2025
Read more →

Agilent Braces For Potential US-EU Tariff Hike, Maintains Annual Outlook

A

Agilent reported Q2 revenue of $1.67 billion and beat EPS estimates. The company raised its 2025 sales forecast and reaffirmed full-year earnings guidance.

May 29, 2025
Read more →

Agilent Technologies Affirms FY2025 Adj EPS Guidance of $5.54-$5.61 vs $5.55 Est; Raises FY2025 Sales Guidance from $6.68B-$6.76B to $6.73B-$6.81B vs $6.73B Est

A

May 28, 2025
Read more →

Agilent Technologies Sees Q3 Adj EPS $1.35-$1.37 vs $1.39 Est; Sees Sales $1.645B-$1.675B vs $1.65B Est

A

May 28, 2025
Read more →

Agilent Technologies Q2 Adj. EPS $1.31 Beats $1.26 Estimate, Sales $1.67B Beat $1.63B Estimate

A

May 28, 2025
Read more →

Wall Street Stalls As Treasury Yields Climb Again Ahead Of Nvidia Earnings, Fed Minutes: What's Driving Markets Wednesday?

A

After a sharp Tuesday rally fueled by optimism over improved U.S.-EU trade ties, Wall Street stalled midweek as rising Treasury yields reasserted pressure ahead of Nvidia Corp.

May 28, 2025
Read more →

Beyond The Numbers: 5 Analysts Discuss Agilent Technologies Stock

A

May 22, 2025
Read more →

Baird Maintains Outperform on Agilent Technologies, Lowers Price Target to $140

A

May 22, 2025
Read more →

Jim Cramer Prefers AutoZone Over Rival: 'Buy The One That's Not Going To Stock Split'

A

AutoZone has outperformed the market over the past 15 years by 10.81% on an annualized basis producing an average annual return of 22.06%.

May 16, 2025
Read more →

How Do Investors Really Feel About Agilent Technologies?

A

May 13, 2025
Read more →

Jefferies Maintains Hold on Agilent Technologies, Lowers Price Target to $116

A

April 21, 2025
Read more →

Breaking Down Agilent Technologies: 5 Analysts Share Their Views

A

April 17, 2025
Read more →

Agilent Technologies Gets European Certification For PD-L1 IHC 22C3 pharmDx To Help Gastric Or GEJ Adenocarcinoma Patients for KEYTRUDA Therapy

A

April 17, 2025
Read more →

Barclays Maintains Equal-Weight on Agilent Technologies, Lowers Price Target to $115

A

April 10, 2025
Read more →

Agilent PD-L1 IHC 28-8 PharmDx Receives EU IVDR Certification As A Companion Diagnostic Test For Non-small Cell Lung Cancer And Melanoma Indications

A

March 10, 2025
Read more →

Goldman Sachs Cuts Earnings Growth Outlook, Sees Investors Move From 'Excitement' To 'Boredom'

A

David Kostin, the Chief U.S. Equity Strategist of Goldman Sachs (NYSE: GS), has revised his earnings growth forecast, citing a weaker economic outlook, and highlighted a shift in market trends.

March 6, 2025
Read more →

How Do Investors Really Feel About Agilent Technologies?

A

March 4, 2025
Read more →

A Glimpse Into The Expert Outlook On Agilent Technologies Through 6 Analysts

A

February 27, 2025
Read more →

Baird Maintains Outperform on Agilent Technologies, Lowers Price Target to $159

A

February 27, 2025
Read more →

Agilent Technologies Sees Q2 Adj. EPS $1.25-$1.28 Vs $1.31 Est.; Revenue $1.61B-$1.65B Vs $1.651B Est.

A

February 26, 2025
Read more →

Agilent Technologies Sees FY25 Adj. EPS $5.54-$5.61 Vs $5.57 Est.; Revenue $6.68B-$6.76B Vs $6.832B Est.

A

February 26, 2025
Read more →

Agilent Technologies Q1 2025 Adj. EPS $1.31 Beats $1.27 Estimate, Sales $1.681B Beat $1.669B Estimate

A

February 26, 2025
Read more →

Earnings Scheduled For February 26, 2025

A

February 26, 2025
Read more →

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor

A

Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.

February 25, 2025
Read more →

Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years

A

December 24, 2024
Read more →

$100 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today

A

November 5, 2024
Read more →

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

A

The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the past week and a look at the reasons why and what's next.

November 1, 2024
Read more →

Looking Into Agilent Technologies's Recent Short Interest

A

November 1, 2024
Read more →

If You Invested $1000 In Agilent Technologies 15 Years Ago, Here's How Much You Would Have Today

A

Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.03% on an annualized basis producing an average annual return of 8.21%. Currently, Agilent Technologies has a market capitalization of $36.29 billion.

April 28, 2022
Read more →